Amphotericin B lipid soluble formulations versus amphotericin B in cancer patients with neutropenia

Medicine & Life Sciences

• Amphotericin B 100%
• Bone Marrow 5%
• Confidence Intervals 24%
• Costs and Cost Analysis 4%
• Creatinine 5%
• Drug Therapy 4%
• Fever 5%
• Infections 3%
• Invasive Fungal Infections 17%
• Lipids 59%
• liposomal amphotericin B 28%
• Magnesium 7%
• Mortality 7%
• Mycoses 7%
• Neoplasms 29%
• Neutropenia 90%
• Pharmaceutical Preparations 5%
• phospholipid emulsion soybean oil 9%
• Potassium 6%
• Premedication 8%
• PubMed 5%
• Randomized Controlled Trials 4%
• Serum 3%
• Transplants 4%